AR016074A1 - Compuestos derivados de di-halo- o tri-halo-benzo [5,6] ciclohepta [1,2-b] piridinas,y una composicion farmaceutica que los comprende. - Google Patents

Compuestos derivados de di-halo- o tri-halo-benzo [5,6] ciclohepta [1,2-b] piridinas,y una composicion farmaceutica que los comprende.

Info

Publication number
AR016074A1
AR016074A1 ARP980102864A ARP980102864A AR016074A1 AR 016074 A1 AR016074 A1 AR 016074A1 AR P980102864 A ARP980102864 A AR P980102864A AR P980102864 A ARP980102864 A AR P980102864A AR 016074 A1 AR016074 A1 AR 016074A1
Authority
AR
Argentina
Prior art keywords
benzo
cyclohepta
chloro
pyridin
dihydro
Prior art date
Application number
ARP980102864A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR016074A1 publication Critical patent/AR016074A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Compuestos derivados de di-halo- o tri-halo-benzo [5,6] ciclohepta[1,2-b]piridinas, que comprenden un compuesto seleccionado de: 1.0) 4-[2-[4-(3-bromo-8-cloro-6,11-dihidro-5H-benzo[5,6]ciclohepta[1,2-b]piridin-11-il]-1-piperidinil]-2-oxoetil]-1-piper idincarboxamida N4-oxido; 2.0)4-[2-[4-(3-bromo-8-cloro-11H-benzo[5,6]ciclohepta[1,2-b]piridin-11-il)-1-piperidinil]-2-oxoetil]-1-piperidincarboxamida N4-oxido; 3.0) 1-(3-bromo-10-cloro-6,11-dihidro-5H-benzo[5,6]ciclohepta[1,2-b]piridin-11-il)-4-(4-pi ridinilacetil)piperazina N1, N4-dioxido; 4.0) 4-(3-bromo-8-cloro-11H-benzo[5,6]ciclohepta[1,2-b]piridin-11-il)-1-(4-piridinil-acetil)piperidina N1-oxido N4-oxido; 5.0) 1-(3-bromo-8-cloro-6,11-dihidro-5H-benzo[5,6]ciclohepta[1,2-b]piridin-11-il)-4-(4- piridinilacetil)piperazinaN1, N4-dioxido; 6.0) 4-[2-[4-(3-bromo-8-cloro-6,11-dihidro-5H--benzo[5,6]ciclohepta[1,2-b]piridin-11-il)-1piperazinil]-2-oxoetil]-1-piperidincarboxamida N-oxido; 7.0)1-(3-bromo-8-cloro-11H-benzo[5,6]ciclohepta[1,2- b]piridin- 11-il)-4-(4-piridinilacetil)piperazina N1,N4-dioxido; 8.0) 4-(3,7-dubromo-8-cloro-5,6-dihidro-1-oxido-11H-benzo[5,6]ciclohepta[1,2-b]piridin-11-ilideno)-1-[(1-oxido-4-piridinil)acetil]piperidina; 9.0) 4-[2-[4-(3,7-dibromo-8-cloro-5,6-dihidro-1-oxido- 11H-benzo[5,6]ciclohepta[1,2-b]piridin-11-ilideno)-1-piperidinil]-2-oxoetil]-1-piperidincarboxamida;10.0) 1-(3,7-dibromo-8-cloro-6,11-dihidro-5H-benzo[5,6]ciclohepta[1,2-b]piridin-11-il)-4-(4-piridinilacetil)piperazina N1, N4-dioxido; 11.0) 4-[2-[4-( 3,7-dibromo-8-cloro-6,11-dihidro-5H-benzo[5,6]ciclohepta[1,2-b]piridin -11-il)-1-piperazinil]-2-oxoetil]-1-piperidincarboxamida N-oxido; 12.0) 4-[2-[4-3,7-dibromo-8-cloro-6,11-dihidro-5H-benzo[5,6]ciclohepta[1,2-b]piridin-11- il)-1-piperidinil]-2-oxoe til]-1-piperidincarboxamida N4-oxido; 13.0) 4-(8-cloro-3,7-dibromo-6,11-5H-benzo[5,6]ciclohepta[1,2-b]piridin-11-il)-1-(4-piridinilacetil)piperidina N1, N4-dioxido; 14.0) 4-(3,10-dibromo-8-cloro-5,6-dihidro-1-oxido-11H-benzo[5,6]ciclohepta[1,2-b]piri din-11-ilideno)-1-[(1-oxido-4-piridinil)acetil]piperidina; 15.0) 4--[2[4-(3,10-dibromo-8-cloro-5,6-dihidro-1-oxido-11H-benzo[5,6]ciclohepta [1,2-b]piridin-11-ilideno)
ARP980102864A 1997-06-17 1998-06-16 Compuestos derivados de di-halo- o tri-halo-benzo [5,6] ciclohepta [1,2-b] piridinas,y una composicion farmaceutica que los comprende. AR016074A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87705797A 1997-06-17 1997-06-17

Publications (1)

Publication Number Publication Date
AR016074A1 true AR016074A1 (es) 2001-06-20

Family

ID=25369159

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102864A AR016074A1 (es) 1997-06-17 1998-06-16 Compuestos derivados de di-halo- o tri-halo-benzo [5,6] ciclohepta [1,2-b] piridinas,y una composicion farmaceutica que los comprende.

Country Status (30)

Country Link
EP (2) EP1156046A1 (es)
JP (1) JP2002504148A (es)
KR (1) KR100588799B1 (es)
CN (1) CN1131228C (es)
AR (1) AR016074A1 (es)
AT (1) ATE222905T1 (es)
AU (1) AU753863B2 (es)
BR (1) BR9811470A (es)
CA (1) CA2294347C (es)
CO (1) CO4940455A1 (es)
CZ (1) CZ297450B6 (es)
DE (1) DE69807477T2 (es)
DK (1) DK0988300T3 (es)
ES (1) ES2178224T3 (es)
HK (1) HK1022908A1 (es)
HU (1) HUP0003046A3 (es)
ID (1) ID30349A (es)
IL (2) IL133449A0 (es)
MY (1) MY117925A (es)
NO (1) NO318938B1 (es)
NZ (1) NZ501618A (es)
PE (1) PE83799A1 (es)
PL (1) PL191866B1 (es)
PT (1) PT988300E (es)
RU (1) RU2220139C2 (es)
SK (1) SK283820B6 (es)
TR (2) TR200003580T2 (es)
TW (1) TW544451B (es)
WO (1) WO1998057959A1 (es)
ZA (1) ZA985210B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9911869A (pt) 1998-07-06 2001-03-27 Janssen Pharmaceutica Nv Inibidores da transferase da proteìna farnesil para o tratamento das artropatias
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
AU3514302A (en) * 2000-11-29 2002-06-11 Schering Corp 0ovel farnesyl protein transferase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them

Also Published As

Publication number Publication date
NO318938B1 (no) 2005-05-30
WO1998057959A1 (en) 1998-12-23
KR100588799B1 (ko) 2006-06-13
PT988300E (pt) 2002-12-31
PE83799A1 (es) 1999-10-23
DE69807477D1 (de) 2002-10-02
MY117925A (en) 2004-08-30
EP0988300B1 (en) 2002-08-28
CA2294347A1 (en) 1998-12-23
TR200000114T2 (tr) 2000-08-21
AU753863B2 (en) 2002-10-31
ES2178224T3 (es) 2002-12-16
TR200003580T2 (tr) 2002-10-21
EP1156046A1 (en) 2001-11-21
IL133449A0 (en) 2001-04-30
BR9811470A (pt) 2000-09-19
HUP0003046A3 (en) 2002-11-28
RU2220139C2 (ru) 2003-12-27
CA2294347C (en) 2008-01-29
CN1131228C (zh) 2003-12-17
NO996236L (no) 2000-02-01
CN1267294A (zh) 2000-09-20
JP2002504148A (ja) 2002-02-05
HK1022908A1 (en) 2000-08-25
TW544451B (en) 2003-08-01
IL133449A (en) 2006-12-10
NZ501618A (en) 2001-10-26
PL191866B1 (pl) 2006-07-31
CZ297450B6 (cs) 2006-12-13
PL337481A1 (en) 2000-08-28
DK0988300T3 (da) 2002-11-25
CO4940455A1 (es) 2000-07-24
ZA985210B (en) 1999-01-07
EP0988300A1 (en) 2000-03-29
SK283820B6 (sk) 2004-02-03
NO996236D0 (no) 1999-12-16
AU8058298A (en) 1999-01-04
SK182499A3 (en) 2000-09-12
DE69807477T2 (de) 2003-02-27
HUP0003046A2 (hu) 2001-06-28
ID30349A (id) 2001-11-22
ATE222905T1 (de) 2002-09-15
CZ447199A3 (cs) 2000-06-14
KR20010013948A (ko) 2001-02-26

Similar Documents

Publication Publication Date Title
DE69300255D1 (de) 8-Chlor-11-(1-(5-methyl-3-pyridyl)methyl-4-piperidyliden)-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)-pyridin.
TR200003888T2 (tr) 4-benzil piperidin alkilsülfoksit heterosiklilleri ve bunların alt tip-selektif NMDA reseptör antagonisti olarak kullanımı
ATE206397T1 (de) 1-(1,2-disubstituierte piperidinyl)-4- substituierte piperidin derivate als tachykinin receptor antagonisten
NO20061528L (no) Polymrofe former av 3-(4-amino-1-okso-1,3dihydro-isoindol-2-yl)-piperidin-2,6-dion
ATE386720T1 (de) Piperidin ccr-3 rezeptor-hemmer
NO982405L (no) 1-(1-2-disubstituert piperidinyl)-4-(kondensert imidazol)-piperidinderivater
HRP20050035B1 (hr) Kristalniäśni 2,5-dion-3-(1-metil-1h-indol-3-il)-4-[1-(piridin-2-ilmetil)piperidin-4-il]-1h-indol-3-il]-1h-pirol monohidroklorid
CA2569861A1 (en) Pyrrolidine derivatives as ccr5 antagonists
UY24973A1 (es) Utilizacion de derivados de tetrahidropiridina para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan una desmielinizacion
AR016074A1 (es) Compuestos derivados de di-halo- o tri-halo-benzo [5,6] ciclohepta [1,2-b] piridinas,y una composicion farmaceutica que los comprende.
NO984380D0 (no) Nye piperazin og piperidin forbindelser
IL155986A0 (en) 4- (biphenylcarbonylamino) piperidine derivatives as mtp inhibitors
FI911133A (fi) Derivat av 4-(aminometyl)piperidin, deras framstaellning och terapeutiska anvaendning.
UY25247A1 (es) Asociacion de principios activos para el tratamiento de la demencia senil de tipo alzheimer
ES8300743A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-(4-arilciclohexil)-piperidinas.
ZA200006224B (en) 8-Chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridene oral compositions.
ATE344244T1 (de) Substituierte 4-phenyl-1-(1-phenyl-cyclohexyl)-1, 2,3,6-tetrahydropyridine
NO20005920D0 (no) Mikroemulsjonsforkonsentrater som inneholder en piperidin stoff P antagonist
AR031725A1 (es) Uso de determinadas sustancias que se fijan en el receptor sigma, para el tratamiento de sarcomas y carcinomas
DE60104822D1 (de) Pseudopolymorph von (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-on hydrochlorid
ZA9610894B (en) 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives.
SI1315700T1 (sl) Substituirani 4-fenil-1-(1-fenil-cikloheksil)-1,2,3,6-tetrahidropiridini

Legal Events

Date Code Title Description
FG Grant, registration